124 related articles for article (PubMed ID: 36179851)
1. Effect of the variation in the extracellular concentration of l-arginine in the physiology of Leishmania (Viannia) braziliensis and its susceptibility to some antileishmanial drugs.
Giraldo M; Upegui YA; Higuita-Castro JL; Gonzalez LA; Gutierrez S; Pulido SA; Robledo SM
Exp Parasitol; 2022 Nov; 242():108395. PubMed ID: 36179851
[TBL] [Abstract][Full Text] [Related]
2. Pterocarpanquinone LQB-118 induces apoptosis in Leishmania (Viannia) braziliensis and controls lesions in infected hamsters.
Costa L; Pinheiro RO; Dutra PM; Santos RF; Cunha-Júnior EF; Torres-Santos EC; da Silva AJ; Costa PR; Da-Silva SA
PLoS One; 2014; 9(10):e109672. PubMed ID: 25340550
[TBL] [Abstract][Full Text] [Related]
3. The alkylaminoalkanethiosulfuric acids exhibit in-vitro antileishmanial activity against Leishmania (Viannia) braziliensis: a new perspective for use of these schistosomicidal agents.
Porcino GN; Antinarelli LMR; Maia ACRG; Faria-Pinto P; Taunay-Rodrigues A; Zech Coelho PM; Nelson DL; Penido MLO; Coimbra ES; Vasconcelos EG
J Pharm Pharmacol; 2019 Dec; 71(12):1784-1791. PubMed ID: 31579947
[TBL] [Abstract][Full Text] [Related]
4. Deprivation of L-Arginine Induces Oxidative Stress Mediated Apoptosis in Leishmania donovani Promastigotes: Contribution of the Polyamine Pathway.
Mandal A; Das S; Roy S; Ghosh AK; Sardar AH; Verma S; Saini S; Singh R; Abhishek K; Kumar A; Mandal C; Das P
PLoS Negl Trop Dis; 2016 Jan; 10(1):e0004373. PubMed ID: 26808657
[TBL] [Abstract][Full Text] [Related]
5. Resveratrol analogues present effective antileishmanial activity against promastigotes and amastigotes from distinct Leishmania species by multitarget action in the parasites.
Antinarelli LMR; Meinel RS; Coelho EAF; da Silva AD; Coimbra ES
J Pharm Pharmacol; 2019 Dec; 71(12):1854-1863. PubMed ID: 31595530
[TBL] [Abstract][Full Text] [Related]
6. The antifungal compound butenafine eliminates promastigote and amastigote forms of Leishmania (Leishmania) amazonensis and Leishmania (Viannia) braziliensis.
Bezerra-Souza A; Yamamoto ES; Laurenti MD; Ribeiro SP; Passero LF
Parasitol Int; 2016 Dec; 65(6 Pt A):702-707. PubMed ID: 27546158
[TBL] [Abstract][Full Text] [Related]
7. An effective in vitro and in vivo antileishmanial activity and mechanism of action of 8-hydroxyquinoline against Leishmania species causing visceral and tegumentary leishmaniasis.
Costa Duarte M; dos Reis Lage LM; Lage DP; Mesquita JT; Salles BC; Lavorato SN; Menezes-Souza D; Roatt BM; Alves RJ; Tavares CA; Tempone AG; Coelho EA
Vet Parasitol; 2016 Feb; 217():81-8. PubMed ID: 26827866
[TBL] [Abstract][Full Text] [Related]
8. L-arginine availability and arginase activity: Characterization of amino acid permease 3 in Leishmania amazonensis.
Aoki JI; Muxel SM; Zampieri RA; Acuña SM; Fernandes JCR; Vanderlinde RH; Sales MCOP; Floeter-Winter LM
PLoS Negl Trop Dis; 2017 Oct; 11(10):e0006025. PubMed ID: 29073150
[TBL] [Abstract][Full Text] [Related]
9. Evidence of Guanidines Potential against
Dos Anjos LR; de Souza VMR; Machado YAA; Partite VM; Aufy M; Dias Lopes G; Studenik C; Alves CR; Lubec G; Gonzalez ERP; Rodrigues KADF
Biomolecules; 2023 Dec; 14(1):. PubMed ID: 38254626
[TBL] [Abstract][Full Text] [Related]
10. The effect of (-)-epigallocatechin 3-O--gallate in vitro and in vivo in Leishmania braziliensis: involvement of reactive oxygen species as a mechanism of action.
Inacio JD; Gervazoni L; Canto-Cavalheiro MM; Almeida-Amaral EE
PLoS Negl Trop Dis; 2014 Aug; 8(8):e3093. PubMed ID: 25144225
[TBL] [Abstract][Full Text] [Related]
11. Antileishmanial activity of azithromycin against Leishmania (Leishmania) amazonensis, Leishmania (Viannia) braziliensis, and Leishmania (Leishmania) chagasi.
de Oliveira-Silva F; de Morais-Teixeira E; Rabello A
Am J Trop Med Hyg; 2008 May; 78(5):745-9. PubMed ID: 18458308
[TBL] [Abstract][Full Text] [Related]
12. Leishmania braziliensis prostaglandin F
Alves-Ferreira EVC; Ferreira TR; Walrad P; Kaye PM; Cruz AK
Parasit Vectors; 2020 Jan; 13(1):9. PubMed ID: 31915065
[TBL] [Abstract][Full Text] [Related]
13. Macromolecular biosynthetic parameters and metabolic profile in different life stages of Leishmania braziliensis: Amastigotes as a functionally less active stage.
Jara M; Berg M; Caljon G; de Muylder G; Cuypers B; Castillo D; Maes I; Orozco MDC; Vanaerschot M; Dujardin JC; Arevalo J
PLoS One; 2017; 12(7):e0180532. PubMed ID: 28742826
[TBL] [Abstract][Full Text] [Related]
14. Salivary gland homogenates from wild-caught sand flies Lutzomyia flaviscutellata and Lutzomyia (Psychodopygus) complexus showed inhibitory effects on Leishmania (Leishmania) amazonensis and Leishmania (Viannia) braziliensis infection in BALB/c mice.
Francesquini FC; Silveira FT; Passero LF; Tomokane TY; Carvalho AK; Corbett CE; Laurenti MD
Int J Exp Pathol; 2014 Dec; 95(6):418-26. PubMed ID: 25476864
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of total phenolic fraction derived from extra virgin olive oil for its antileishmanial activity.
Koutsoni OS; Karampetsou K; Kyriazis ID; Stathopoulos P; Aligiannis N; Halabalaki M; Skaltsounis LA; Dotsika E
Phytomedicine; 2018 Aug; 47():143-150. PubMed ID: 30166099
[TBL] [Abstract][Full Text] [Related]
16. Murine macrophages do not support the proliferation of Leishmania (Viannia) braziliensis amastigotes even in absence of nitric oxide and presence of high arginase activity.
Teixeira MV; Soares SAE; Souza VA; de Souza Marques AM; de Almeida Soares CM; Baeza LC; de Oliveira MAP
Parasitol Res; 2022 Oct; 121(10):2891-2899. PubMed ID: 35939146
[TBL] [Abstract][Full Text] [Related]
17. First evidence of a serine arginine protein kinase (SRPK) in leishmania braziliensis and its potential as therapeutic target.
Pimentel DC; Leopoldo JR; Teixeira LF; Barros MVA; de Souza APM; Onofre TS; de Carvalho RL; Machado SA; Messias IG; Pinto CCS; Poleto MD; Diogo MA; Mariotini-Moura C; Bressan GC; Teixeira RR; Fietto JLR; Vasconcellos RS
Acta Trop; 2023 Feb; 238():106801. PubMed ID: 36563831
[TBL] [Abstract][Full Text] [Related]
18. Intraspecies susceptibility of Leishmania (Viannia) braziliensis to antileishmanial drugs: Antimony resistance in human isolates from atypical lesions.
Rugani JN; Quaresma PF; Gontijo CF; Soares RP; Monte-Neto RL
Biomed Pharmacother; 2018 Dec; 108():1170-1180. PubMed ID: 30372818
[TBL] [Abstract][Full Text] [Related]
19. Testing of four Leishmania vaccine candidates in a mouse model of infection with Leishmania (Viannia) braziliensis, the main causative agent of cutaneous leishmaniasis in the New World.
Salay G; Dorta ML; Santos NM; Mortara RA; Brodskyn C; Oliveira CI; Barbiéri CL; Rodrigues MM
Clin Vaccine Immunol; 2007 Sep; 14(9):1173-81. PubMed ID: 17626159
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of macrophage invasion by monoclonal antibodies specific to Leishmania (Viannia) braziliensis promastigotes and characterisation of their antigens.
Silveira TG; Suzuki E; Takahashi HK; Straus AH
Int J Parasitol; 2001 Nov; 31(13):1451-8. PubMed ID: 11595232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
